Boston Family Office LLC Eli Lilly & CO Transaction History

Boston Family Office LLC

$1.39 Billion
Q2 2024

A detailed history of Boston Family Office LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Boston Family Office LLC holds 5,567 shares of LLY stock, worth $4.56 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

5,567

Previous 5,587 0.36%

Holding current value

$4.56 Million

Previous $4.35 Million 15.97%

% of portfolio

0.36%

Previous 0.31%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $14,497 - $18,180	-20 Reduced 0.36%	5,567 $5.04 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $213,192 - $285,220	-360 Reduced 6.05%	5,587 $4.35 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $161,233 - $190,072	-307 Reduced 4.91%	5,947 $3.47 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $412,095 - $568,136	-948 Reduced 13.16%	6,254 $3.36 Million
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $5,591 - $6,566	-18 Reduced 0.25%	7,202 $2.47 Million
Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $10,289 - $11,989	-32 Reduced 0.44%	7,220 $2.64 Million
Q3 2022 Nov 08, 2022	SELL	$296.48 - $337.87 $592,663 - $675,402	-1,999 Reduced 21.61%	7,252 $2.34 Million
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $41,809 - $49,090	-150 Reduced 1.6%	9,251 $3 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $28,106 - $34,880	125 Added 1.35%	9,401 $2.6 Million
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $4,513 - $5,838	-25 Reduced 0.27%	9,276 $2.13 Million
Q1 2021 May 07, 2021	SELL	$164.32 - $212.72 $48,967 - $63,390	-298 Reduced 3.1%	9,301 $1.77 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $15,133 - $20,025	-116 Reduced 1.19%	9,599 $1.62 Million
Q3 2020 Nov 10, 2020	SELL	$146.22 - $169.13 $1,608 - $1,860	-11 Reduced 0.11%	9,715 $1.44 Million
Q1 2020 May 11, 2020	SELL	$119.05 - $147.35 $5,952 - $7,367	-50 Reduced 0.51%	9,726 $1.35 Million
Q2 2019 Jul 30, 2019	BUY	$110.79 - $129.32 $1,218 - $1,422	11 Added 0.11%	9,776 $1.08 Million
Q1 2019 May 09, 2019	SELL	$111.31 - $131.02 $5,565 - $6,551	-50 Reduced 0.51%	9,765 $1.27 Million
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $10,590 - $11,864	-100 Reduced 1.01%	9,815 $1.14 Million
Q4 2017 Feb 06, 2018	SELL	$81.94 - $87.89 $54,490 - $58,446	-665 Reduced 6.29%	9,915 $837,000
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $815,400 - $905,013	10,580	10,580 $905,000

Others Institutions Holding LLY

# of Institutions

3,912

Shares Held

765M

Call Options Held

6.35M

Put Options Held

7.96M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $778B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Family Office LLC with notifications on news.

Account

Boston Family Office LLC Eli Lilly & CO Transaction History